CANF Competitors & Alternatives
Compare Can Fite Biopharma Ltd ADR with similar stocks in the same industry
Biotechnology
CANF
Main Stock$3.91
Tradestie Score
54
Market Cap
$9.67M
Revenue Growth
-0.4%
Analyst Upside
+27.9%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANRO
Alto Neuroscience Inc.
|
$24.78
|
$110.20M | - | 58 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.69
|
$97.42M | - | 55 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$30.43
|
$76.55M | - | 58 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.28
|
$71.69M | - | 52 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.34
|
$67.94M | - | 56 | Compare |
|
BLRX
BioLineRX Ltd
|
$3.29
|
$16.50M | - | 54 | Compare |
|
RDHL
Redhill Biopharma Ltd.
|
$0.81
|
$8.39M | - | 45 | Compare |
|
CETX
CEMTREX INC.
|
$2.97
|
$4.26M | 0.0 | 44 | Compare |
|
HEPA
HEPA
|
- | - | - | - | Compare |
|
CFOR
CFOR
|
- | - | - | - | Compare |
More CANF Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2834)
237 stocks in this industry